Victory Capital Management
DNA icon

Victory Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Victory Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-179,570
Closed -$1.46M – 2490
2024
Q3 		$1.46M Buy
179,570
+175,040
+3,864% +$1.75M ﹤0.01% 1606
2024
Q2 		$60.6K Buy
4,530
+110
+2% +$3.28K ﹤0.01% 2347
2024
Q1 		$205K Sell
4,420
-34
-0.8% -$1.76K ﹤0.01% 2217
2023
Q4 		$301K Buy
4,454
+979
+28% +$59.9K ﹤0.01% 2125
2023
Q3 		$252K Buy
3,475
+47
+1% +$3.76K ﹤0.01% 2161
2023
Q2 		$255K Buy
3,428
+620
+22% +$36.7K ﹤0.01% 2146
2023
Q1 		$149K Buy
2,808
+79
+3% +$5.01K ﹤0.01% 2301
2022
Q4 		$184K Buy
2,729
+513
+23% +$47.2K ﹤0.01% 2282
2022
Q3 		$277K Sell
2,216
-1,761
-44% -$210K ﹤0.01% 2275
2022
Q2 		$379K Sell
3,977
-18
-0.5% -$2.19K ﹤0.01% 2166
2022
Q1 		$463K Sell
3,995
-4,476
-53% -$871K ﹤0.01% 2150
2021
Q4 		$2.82M Buy
+8,471
New +$4.02M ﹤0.01% 1455

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return